SeamlessBio Editorial · June 2026 · 9 min read · ← All Articles

HSA vs rHSA — Which Albumin Grade Do You Actually Need?

Plasma-derived, Research, ISO 13485 Near-GMP, GMP Grade — four fundamentally different products sold under the same name. Here is what each label actually means and why getting it wrong costs you regulatory time.

Human Serum Albumin is the most abundant protein in human blood plasma — and one of the most widely used raw materials in biopharmaceutical manufacturing. Cell culture supplement, drug formulation excipient, cryopreservation component, protein stabiliser in AAV vectors and CAR-T cell therapy products. The problem: "HSA" on a datasheet means very different things depending on source, production method, and quality system.

The Four Grades at a Glance

Grade 1 — Plasma-Derived HSA PLASMA

Purified from pooled human plasma via Cohn cold-ethanol fractionation. Native human albumin structure — structurally identical to albumin in the human body. Full viral testing per lot. ISO 13485 quality documentation from own EU/US donor centre network.

Best for: IVD diagnostic reagent development, clinical chemistry calibrators, Western blot / ELISA blocking, drug formulation development, cell culture where human protein source is preferred over BSA.

Grade 2 — rHSA Research / Economy Grade RESEARCH

Recombinant HSA produced in yeast (S. cerevisiae, P. pastoris) or rice (O. sativa). 100% animal-origin-free — no human plasma, no donor variability, no blood-borne pathogen risk. Lot-specific CoA covering purity, endotoxin, and protein concentration. Does not include ISO 13485 certification, process validation documentation, or the traceability package required for regulatory submissions.

The correct choice for R&D and process development — establish whether rHSA works in your system before committing to the higher documentation overhead of a regulated grade.

Best for: Serum-free media formulation development, iPSC feeder-free culture optimisation, AAV formulation buffer (0.001–0.01% to prevent capsid adsorption), protocol development before GMP commitment.

Grade 3 — rHSA ISO 13485 / Near-GMP ISO 13485

This is where most of the market confusion lives. ISO 13485 certifies that manufacturing processes are controlled, validated, documented, and traceable. It does not certify that a facility has been inspected by EMA or FDA under pharmaceutical GMP. The difference matters for IND submissions.

SeamlessBio's Near-GMP rHSA has an additional differentiator: our supply chain is built on our own EU donor centre network — direct traceability from raw material origin to finished product. Most distributors, even ISO 13485-certified ones, cannot provide this level of supply chain transparency. In IND-enabling scenarios, this substantially strengthens the risk-based justification.

Best for: CAR-T process development (pre-Phase I), IND-enabling iPSC manufacturing, vaccine formulation pre-clinical and Phase I-enabling, advanced diagnostics manufacturing under ISO 13485.

Grade 4 — rHSA Full GMP Grade GMP

Full pharmaceutical GMP manufactured under Eudralex Vol. 4 and 21 CFR Part 211 in an EMA/FDA GMP-inspected facility. Batch manufacturing records. Qualified Person release. Ph. Eur. 5.2.12 documentation as standard. Direct acceptability for Phase I/II ATMP clinical manufacturing — no risk-based justification required.

Best for: Phase I/II CAR-T clinical manufacturing, licensed vaccine product formulation, GMP master cell bank preparation, any application where the regulatory authority has explicitly specified full GMP ancillary material.

The Decision Matrix — Stage-Appropriate Selection

The most common mistake is assuming ISO 13485 equals pharmaceutical GMP and building an IND submission around documentation that regulators will question. The second most common mistake is the opposite: buying full GMP for early process development and paying a 3–5× cost premium for documentation not yet required.

The practical advantage of sourcing all grades from one supplier: qualification — supplier audit, documentation review, change notification system — happens once. As your programme progresses from R&D to IND-enabling to clinical manufacturing, you move up the grade ladder with the same supplier documentation system.

Why EU Supply Chain Traceability Matters

For European manufacturers submitting to EMA, EU origin and supply chain traceability for albumin as an ancillary material is increasingly a regulatory expectation. SeamlessBio's albumin supply chain is built on our own EU donor centre network — not third-party distributors. For every lot supplied, we have direct documentation of raw material origin, collection conditions, and processing steps. This level of traceability is the foundation of our Near-GMP grade's regulatory strength.

Further Information

• Full HSA vs rHSA Grade Comparison — complete tables and documentation requirements
• HSA Product Overview — all grades with specifications
• CAR-T Manufacturing Guide — albumin in cell therapy context
• Order Plasma-Derived HSA in Shop

Technical enquiries, regulatory documentation, batch reservation: info@seamlessbio.de | +49 851 37932226